TechFlow reported on July 11 that, according to TheBlock, the FTX-Alameda bankruptcy court has challenged a $264 million claim filed by Jump Trading subsidiary Tai Mo Shan over a loan transaction involving Alameda Research. Tai Mo Shan claims Alameda Research failed to deliver 800 million Serum (SRM) tokens—originating from a loan agreement signed in August 2020—resulting in nearly $264 million in losses. FTX's legal team has requested the court dismiss the lawsuit, arguing that Alameda Research never actually provided the loan, and further contending that Jump Trading’s claimed damages of $264 million are "baseless," with the calculation using an "options model" being vague and inadequately explained.
Add to Favorites
Share to Social Media
